Spedizione gratuita per ordini superiori a 69,99 euro.

Controllare lo stato dell'ordine

Entra a far parte di una comunità di amanti dei libri di tutto il mondo e ottieni numerosi vantaggi. Crea un account gratuito

Punto Poste 5.49 € Punto Poste 5.49 € Corriere DHL 6.99 € Corriere GLS 5.99 € Punto GLS 4.49 € Corriere Bartolini 4.49 € Punto Bartolini 3.49 €

Contatto

Come acquistare

Aiuto

Il mio account

▸ Vuoto :-(

Spedizione gratuita per ordini superiori a 69,99 euro.

Intellectual Property and Emerging Technologies

The New Biology

Matthew Rimmer

Alison Mclennan

Lingua

Inglese

Libro Rigido

Codice Libristo: 05107597

Casa editrice Edward Elgar Publishing Ltd, gennaio 2012

This unique and comprehensive collection investigates the challenges posed to intellectual property... Descrizione completa

Codice Libristo: 05107597

591 b

241.29 €

Magazzino esterno Inviamo tra 14-20 giorni

Fino a 30 giorni per il reso

I clienti hanno acquistato anche

Mémo Révisions PASS & L.AS - 2e éd. Salah Belazreg Libro

In brossura

17.39 €

Star Wars - Haute République #7 Temptation of the Force Tessa Gratton

In brossura

12.09 €

3306T Zermatt - Saas-Fee Wanderkarte Bundesamt für Landestopografie swisstopo

Mappa

11.39 €

Dřevěné puzzle Barevné štěně 501 dílků

Puzzle

24.19 €

Mitterrand et la réunification allemande Tilo Schabert

Libro

51.09 €

Kompletny przewodnik po DAX Russo Marco

In brossura

30.49 €

The Case Study Of Vanitas 6 Jun Mochizuki

In brossura

7.29 €

Diesseits und Jenseits des Oceans Gustav Struve

In brossura

18.59 €

Malen'kij krot, kotoryj hotel znat', kto nadelal emu na golovu Werner Holzwarth

Rigido

14.69 €

This unique and comprehensive collection investigates the challenges posed to intellectual property by recent paradigm shifts in biology. It explores the legal ramifications of emerging technologies, such as genomics, synthetic biology, stem cell research, nanotechnology, and biodiscovery. Extensive contributions examine recent controversial court decisions in patent law - such as Bilski v. Kappos, and the litigation over Myriad's patents in respect of BRCA1 and BRCA2 - while other papers explore sui generis fields, such as access to genetic resources, plant breeders' rights, and traditional knowledge. The collection considers the potential and the risks of the new biology for global challenges - such as access to health-care, the protection of the environment and biodiversity, climate change, and food security. It also considers Big Science projects - such as biobanks, the 1000 Genomes Project, and the Doomsday Vault. The inter-disciplinary research brings together the work of scholars from Australia, Canada, Europe, the UK, and the US and involves not only legal analysis of case law and policy developments, but also historical, comparative, sociological, and ethical methodologies. Intellectual Property and Emerging Technologies will appeal to policy-makers, legal practitioners, business managers, inventors, scientists, and researchers.